As of 2025-09-17, the Intrinsic Value of Biovaxys Technology Corp (BIOV.CN) is -0.79 CAD. This BIOV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.23 CAD, the upside of Biovaxys Technology Corp is -452.11%.
Based on its market price of 0.23 CAD and our intrinsic valuation, Biovaxys Technology Corp (BIOV.CN) is overvalued by 452.11%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.79 - -0.79 | -0.79 | -452.11% |
| P/E | (0.01) - (0.01) | (0.01) | -103.5% |
| DDM - Stable | (3.49) - 52.18 | 24.34 | 10718.9% |
| DDM - Multi | (2.48) - 28.55 | (5.40) | -2498.8% |
| Market Cap (mil) | 7.87 |
| Beta | -0.02 |
| Outstanding shares (mil) | 34.98 |
| Enterprise Value (mil) | 7.78 |
| Market risk premium | 5.10% |
| Cost of Equity | 5.45% |
| Cost of Debt | 5.00% |
| WACC | 5.44% |